Prognostic Nomogram of Extranodal NK/T-cell Lymphoma

Sun Yat-sen University1,000 enrolled

Overview

This study aims to evaluate prognostic factors for overall survival and explore risk progression-free survival in ENKTL, and establish a prognostic predictive nomogram for ENKTL patients.

This is a retrospective cohort study using anonymized information from patients with ENKTL. The following criteria are required: (1) Patients diagnosed with ENKTL between January 1, 2000 and August 31, 2020; (2) Patients older than 18 years. The pathology of initial diagnosis was reviewed by designated pathologists.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Extranodal NK/T-cell Lymphoma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients newly diagnosed with ENKTL * Patients diagnosed between January 1, 2000 and August 31, 2020 * Patients older than 18 years Exclusion Criteria: * Patients who did not have complete clinical information or immunohistochemistry, or who were lost follow-up immediately after treatment.

Locations (1)

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China

RECRUITING

Outcomes

Primary Outcomes

Overall survival

Time between the date of diagnosis and any kinds of death

Time frame: 5 year

Secondary Outcomes

Progression-free survival

Time between the date of diagnosis and any kinds of death or relapse/progression

Time frame: 5 year

Central Contacts

Hua Wang

CONTACT

+862087342462 wanghua@sysucc.org.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.